Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property

Go back to Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
(NASDAQ: ENVB) Delayed: 1.35 +0.04 (3.05%)
Previous Close $1.31    52 Week High
Open $1.34    52 Week Low
Day High $1.35    P/E N/A 
Day Low $1.29    EPS
Volume 100,324